ATYR logo

aTyr Pharma (ATYR)

Profile

Full Name

aTyr Pharma, Inc.

Ticker Symbol

ATYR

Exchange

NASDAQ

Country

United States

IPO

Indexes

Not included

Employees

56

Key Details

Price

$2.97(+8.39%)

Market cap

$263.91M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$235.00K(-33.43% YoY)

Annual EPS

-$0.86(+8.51% YoY)

PE ratio

-

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 14, 25 HC Wainwright & Co.
Buy
Feb 18, 25 Leerink Partners
Outperform
Jan 6, 25 Cantor Fitzgerald
Overweight
Dec 10, 24 HC Wainwright & Co.
Buy
Dec 3, 24 HC Wainwright & Co.
Buy
Oct 29, 24 HC Wainwright & Co.
Buy
Oct 4, 24 Wells Fargo
Overweight
Sep 5, 24 Jefferies
Buy
Aug 15, 24 HC Wainwright & Co.
Buy
Aug 14, 24 RBC Capital
Outperform

Institutional Ownership

  • What is the ticker symbol for aTyr Pharma?
  • Does aTyr Pharma pay dividends?
  • What sector is aTyr Pharma in?
  • What industry is aTyr Pharma in?
  • What country is aTyr Pharma based in?
  • Is aTyr Pharma in the S&P 500?
  • Is aTyr Pharma in the NASDAQ 100?
  • Is aTyr Pharma in the Dow Jones?
  • When was aTyr Pharma's last earnings report?
  • When does aTyr Pharma report earnings?
  • Should I buy aTyr Pharma stock now?

What is the ticker symbol for aTyr Pharma?

The ticker symbol for aTyr Pharma is NASDAQ:ATYR

Does aTyr Pharma pay dividends?

No, aTyr Pharma does not pay dividends

What sector is aTyr Pharma in?

aTyr Pharma is in the Healthcare sector

What industry is aTyr Pharma in?

aTyr Pharma is in the Biotechnology industry

What country is aTyr Pharma based in?

aTyr Pharma is headquartered in United States

Is aTyr Pharma in the S&P 500?

No, aTyr Pharma is not included in the S&P 500 index

Is aTyr Pharma in the NASDAQ 100?

No, aTyr Pharma is not included in the NASDAQ 100 index

Is aTyr Pharma in the Dow Jones?

No, aTyr Pharma is not included in the Dow Jones index

When was aTyr Pharma's last earnings report?

aTyr Pharma's most recent earnings report was on Mar 13, 2025

When does aTyr Pharma report earnings?

The next expected earnings date for aTyr Pharma is May 2, 2025

Should I buy aTyr Pharma stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page